Efficacy of Capmatinib in Laos

Capmatinib (Capmatinib) is a targeted therapy drug for specific types of cancer. It is mainly used to treat MET Primary tyrosine kinase overexpression (< patients with advanced or metastatic non-small cell lung cancer (NSCLC) with span>METex14skipping mutations or METincreased). Its main functions are as follows:

1.Inhibition of tumor growth: Capmatinib inhibits the growth and proliferation of tumor cells by specifically inhibiting the activity of METtyrosine kinase and blocking the MET signaling pathway. MET is abnormally expressed in certain cancer cells, leading to abnormal cell proliferation. The role of capmatinib is to interfere with this process and prevent the further spread and spread of tumor cells.

2.Inhibition of metastasis: Capmatinib can also inhibit the metastasis ability of the MET signaling pathway and prevent cancer cells from metastasizing to other tissues and organs. This is important in preventing cancer progression and metastasis, helping to control the local and distant spread of tumors.

3.Targeted therapy: Capmatinib is a targeted therapy drug that mainly acts onMETkinase, reducing the impact on healthy cells to a certain extent. Compared with traditional chemotherapy, targeted therapy drugs often have better safety and tolerability.

It should be emphasized that the efficacy and effect of the drug vary between individuals, so the efficacy of capmatinib will vary in different patients. Doctors will determine whether capmatinib is suitable for use based on the patient's specific conditions, such as the severity of the disease and the molecular characteristics of the tumor, and formulate an individualized treatment plan. During the use of the drug, efficacy and adverse reactions should be closely monitored to ensure the best therapeutic effect of the drug.

Capmatinib is not currently on the market in China, so patients cannot purchase it domestically. Capmatinib abroad is divided into original drugs and generic drugs. The original drug is mainly the original drug from Novartis, with a price of about 35,000 yuan and a specification of 200mg*60; the price of generic drugs is very cheap, mainly Laos generic drugs, with a price of about 3,000 to 4,000 yuan. The ingredients of original drugs and generic drugs are basically the same.